Company Filing History:
Years Active: 1976
Title: Werner Forster: Innovator in Antiarrhythmic Compounds
Introduction
Werner Forster is a notable inventor based in Halle, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antiarrhythmic agents. His work has implications for the treatment of heart rhythm disorders.
Latest Patents
Forster holds a patent for "21-Deoxydihydroajmaline derivatives." This patent describes novel 21-deoxydihydroajmaline derivatives characterized by their antiarrhythmic activity. The compounds have the formula where R and R' are each the same alkyl group of 2 to 4 carbon atoms, or R and R' together with the associated nitrogen atom form a saturated 5- or 6-atom ring. The remaining atoms are either carbon or one oxygen atom, with X representing the anion of a physiologically inorganic or organic acid.
Career Highlights
Werner Forster has worked at Veb Arzneimittelwerk Dresden, a company known for its focus on pharmaceutical development. His research has led to advancements in the understanding and treatment of cardiac conditions.
Collaborations
Throughout his career, Forster has collaborated with notable colleagues, including Klaus Braun and Gunther Gabsch. These partnerships have contributed to the success of his research and the development of innovative compounds.
Conclusion
Werner Forster's contributions to the field of antiarrhythmic compounds highlight his role as an important inventor in medicinal chemistry. His patented work continues to influence the development of treatments for heart rhythm disorders.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.